Study brain and thinking effects after CAR T therapy in youth
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how CAR T-cell treatment affects thinking, learning, and day-to-day brain function in children and young adults with certain blood cancers. You (and a caregiver) may complete online testing so researchers can track these changes over time and whether support is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have relapsed or refractory leukemia or lymphoma and be scheduled for CAR T-cell therapy at a participating site
- Be age 5 to 35 years old
- Have an available caregiver (age 18+) willing to help with online brain tests and check-in surveys
- Be able to speak and understand English or Spanish (and the caregiver can read English/Spanish)
- Use a computer or tablet with a camera and internet for remote study visits/assessments
- Not have a pre-existing global intellectual disability (for example, Down syndrome)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well CAR-T cell therapy works and how safely it can be given to older adults. It is for people whose cancer or related blood condition has come back or did not respond, and who are receiving a standard (commercial) CAR-T product.
This trial tests a new CAR T-cell therapy made locally for children and young adults with B-cell cancers that have come back or not responded to other treatments. The therapy uses your own immune cells, modified to find and attack cancer cells.
This study tests whether extra geriatric support before and after CAR-T cell therapy helps people 60 and older recover faster. It is for patients with B-cell non-Hodgkin lymphoma or multiple myeloma who are scheduled for an FDA-approved CAR-T treatment.
This study looks at how thinking and brain function change over time in people with lymphoma who receive CAR T therapy. It may help doctors understand side effects and better support patients during and after treatment.
This study watches patients getting CAR-T cell therapy to see if it affects brain function, thinking, or memory. It aims to find out how common these effects are and help doctors manage them.
This study looks at how CAR-T cell therapy affects memory and thinking skills in adults with certain types of lymphoma. The results may help doctors understand and support patients better during treatment.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.